Sign in to view content

Efficacy, Safety, and Durability of Faricimab in Macular Edema Due to Retinal Vein Occlusion: 72-Week Results From the Phase 3 BALATON and COMINO Trials

Carl J Danzig, MD

Video
Published 2024

Related

Baseline and Early Treatment Response Variables Associated With Faricimab Durability in Treatment-Naive nAMD: TENAYA/LUCERNE Post Hoc Analyses
Benjamin Bakall, MD, PhD
Annual Meeting Talks
2025
Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Annual Meeting Talks
2024
An analysis of the phase 2 trial with intraviteal aflibercept and suprachoroidal
Michael A. Singer, MD
Updates from the Field
2017

Category: Retinal Vascular Disease

See more